
Kathrine A. Seeberg
- Consultant; MD, PhD
Mini CV
Education:
- MD University of Oslo (2001)
- PhD University of Oslo (2024)
- Norwegian clinical specialist accreditations:
Internal medicine (2011) and gastroenterology (2011)
Current position:
Consultant, Department of Gastroenterology, Oslo University Hospital
Publications 2023
The liver-heart axis in patients with severe obesity: The association between liver fibrosis and chronic myocardial injury may be explained by shared risk factors of cardiovascular disease
Clin Biochem, 123, 110688
DOI 10.1016/j.clinbiochem.2023.110688, PubMed 37995847
Publications 2022
Association between hepatic steatosis and fibrosis with measures of insulin sensitivity in patients with severe obesity and type 2 diabetes - a cross-sectional study
BMC Gastroenterol, 22 (1), 448
DOI 10.1186/s12876-022-02550-0, PubMed 36336684
Publications 2021
Gastric Bypass Versus Sleeve Gastrectomy in Type 2 Diabetes: Effects on Hepatic Steatosis and Fibrosis : A Randomized Controlled Trial
Ann Intern Med, 175 (1), 74-83
DOI 10.7326/M21-1962, PubMed 34843380
Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients With Chronic Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial
JAMA, 325 (17), 1744-1754
DOI 10.1001/jama.2021.4172, PubMed 33944876
Effect of Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial
JAMA, 326 (23), 2375-2384
DOI 10.1001/jama.2021.21316, PubMed 34932077
Publications 2020
Efficacy and Safety of CT-P13 in Inflammatory Bowel Disease after Switching from Originator Infliximab: Exploratory Analyses from the NOR-SWITCH Main and Extension Trials
BioDrugs, 34 (5), 681-694
DOI 10.1007/s40259-020-00438-7, PubMed 32965617
Publications 2019
Single-centre, triple-blinded, randomised, 1-year, parallel-group, superiority study to compare the effects of Roux-en-Y gastric bypass and sleeve gastrectomy on remission of type 2 diabetes and β-cell function in subjects with morbid obesity: a protocol for the Obesity surgery in Tønsberg (Oseberg) study
BMJ Open, 9 (6), e024573
DOI 10.1136/bmjopen-2018-024573, PubMed 31167860
Long-term efficacy and safety of biosimilar infliximab (CT-P13) after switching from originator infliximab: open-label extension of the NOR-SWITCH trial
J Intern Med, 285 (6), 653-669
DOI 10.1111/joim.12880, PubMed 30762274
Publications 2010
[A man presenting with fever and abdominal pain]
Tidsskr Nor Laegeforen, 130 (18), 1830-2
DOI 10.4045/tidsskr.09.0385, PubMed 20882082